Index by author

January 01, 2024; Volume 91,Issue 1

  1. Agrawal, Ankit

    1. When should we consider SGLT-2 inhibitors in patients with acute decompensated heart failure?
      Osamah Z. Badwan, MD, Lorenzo Braghieri, MD, Warren Skoza, MD, Ankit Agrawal, MD, Venu Menon, MD and W. H. Wilson Tang, MD
      Cleveland Clinic Journal of Medicine January 2024, 91 (1) 47-51; DOI: https://doi.org/10.3949/ccjm.91a.23034

      Evidence from clinical trials supports starting these medications as early as possible in patients hospitalized with acute decompensated heart failure who do not have clear contraindications to them.

  2. Alexander, Jason T.

    1. 2023 Update in ambulatory general internal medicine
      Jason T. Alexander, MD, Simran K. Singh, MD, Sachin D. Shah, MD, Brianna Lambert, MD and Jeremy P. Smith, MD
      Cleveland Clinic Journal of Medicine January 2024, 91 (1) 40-46; DOI: https://doi.org/10.3949/ccjm.91a.23056

      Topics reviewed include prevention of chronic kidney disease progression, diet for preventing secondary cardiovascular disease, prevention of kidney-stone recurrence, drug therapy for weight loss, and cholesterol management.

  3. Alomari, Mohammad

    1. Gastric intestinal metaplasia and gastric cancer prevention: Watchful waiting
      Shrouq Khazaaleh, MD, Mohammad Alomari, MD, Mamoon Ur Rashid, MD, Daniel Castaneda, MD and Fernando J. Castro, MD
      Cleveland Clinic Journal of Medicine January 2024, 91 (1) 33-39; DOI: https://doi.org/10.3949/ccjm.91a.23015

      Malignancy develops in only a small minority of patients with gastric intestinal metaplasia. Recognition of clinical, endoscopic, and histologic features linked with cancer development is critical to identifying patients who require endoscopic surveillance.

  4. Badwan, Osamah Z.

    1. When should we consider SGLT-2 inhibitors in patients with acute decompensated heart failure?
      Osamah Z. Badwan, MD, Lorenzo Braghieri, MD, Warren Skoza, MD, Ankit Agrawal, MD, Venu Menon, MD and W. H. Wilson Tang, MD
      Cleveland Clinic Journal of Medicine January 2024, 91 (1) 47-51; DOI: https://doi.org/10.3949/ccjm.91a.23034

      Evidence from clinical trials supports starting these medications as early as possible in patients hospitalized with acute decompensated heart failure who do not have clear contraindications to them.

  5. Batur, Pelin

    1. Late complications after allogeneic hematopoietic cell transplant
      Pelin Batur, MD, FACP, MSCP
      Cleveland Clinic Journal of Medicine January 2024, 91 (1) 19; DOI: https://doi.org/10.3949/ccjm.91c.01001

  6. Braghieri, Lorenzo

    1. When should we consider SGLT-2 inhibitors in patients with acute decompensated heart failure?
      Osamah Z. Badwan, MD, Lorenzo Braghieri, MD, Warren Skoza, MD, Ankit Agrawal, MD, Venu Menon, MD and W. H. Wilson Tang, MD
      Cleveland Clinic Journal of Medicine January 2024, 91 (1) 47-51; DOI: https://doi.org/10.3949/ccjm.91a.23034

      Evidence from clinical trials supports starting these medications as early as possible in patients hospitalized with acute decompensated heart failure who do not have clear contraindications to them.

  7. Buda, Kevin G.

    1. Consumer-grade wearable cardiac monitors: What they do well, and what needs work
      Consumer-grade wearable cardiac monitors: What they do well, and what needs work
      Abdilahi Mohamoud, MBBS, Joseph Jensen, MD and Kevin G. Buda, DO
      Cleveland Clinic Journal of Medicine January 2024, 91 (1) 23-29; DOI: https://doi.org/10.3949/ccjm.91a.23030

      The authors review common consumer-grade wearables, including the accuracy of these monitors compared with medical-grade devices, and present an approach to managing rate or rhythm abnormalities identified on at-home monitoring.

  8. Castaneda, Daniel

    1. Gastric intestinal metaplasia and gastric cancer prevention: Watchful waiting
      Shrouq Khazaaleh, MD, Mohammad Alomari, MD, Mamoon Ur Rashid, MD, Daniel Castaneda, MD and Fernando J. Castro, MD
      Cleveland Clinic Journal of Medicine January 2024, 91 (1) 33-39; DOI: https://doi.org/10.3949/ccjm.91a.23015

      Malignancy develops in only a small minority of patients with gastric intestinal metaplasia. Recognition of clinical, endoscopic, and histologic features linked with cancer development is critical to identifying patients who require endoscopic surveillance.

  9. Castro, Fernando J.

    1. Gastric intestinal metaplasia and gastric cancer prevention: Watchful waiting
      Shrouq Khazaaleh, MD, Mohammad Alomari, MD, Mamoon Ur Rashid, MD, Daniel Castaneda, MD and Fernando J. Castro, MD
      Cleveland Clinic Journal of Medicine January 2024, 91 (1) 33-39; DOI: https://doi.org/10.3949/ccjm.91a.23015

      Malignancy develops in only a small minority of patients with gastric intestinal metaplasia. Recognition of clinical, endoscopic, and histologic features linked with cancer development is critical to identifying patients who require endoscopic surveillance.

  10. Cho, Leslie S.

    1. Nonstatin therapy to reduce low-density lipoprotein cholesterol and improve cardiovascular outcomes
      Abhayjit Singh, MD and Leslie S. Cho, MD
      Cleveland Clinic Journal of Medicine January 2024, 91 (1) 53-63; DOI: https://doi.org/10.3949/ccjm.91a.23058

      Several new nonstatin medications have been approved in recent years, with robust data from clinical trials supporting their use in atherosclerotic disease.

« Previous (Pages : 1 2 3 ... 3) Next »
Back to top

In this issue